1. Home
  2. CATX vs GCO Comparison

CATX vs GCO Comparison

Compare CATX & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CATX
  • GCO
  • Stock Information
  • Founded
  • CATX 1983
  • GCO 1924
  • Country
  • CATX United States
  • GCO United States
  • Employees
  • CATX N/A
  • GCO N/A
  • Industry
  • CATX Medical/Dental Instruments
  • GCO Clothing/Shoe/Accessory Stores
  • Sector
  • CATX Health Care
  • GCO Consumer Discretionary
  • Exchange
  • CATX Nasdaq
  • GCO Nasdaq
  • Market Cap
  • CATX 239.0M
  • GCO 238.4M
  • IPO Year
  • CATX N/A
  • GCO N/A
  • Fundamental
  • Price
  • CATX $3.44
  • GCO $22.34
  • Analyst Decision
  • CATX Strong Buy
  • GCO Hold
  • Analyst Count
  • CATX 10
  • GCO 2
  • Target Price
  • CATX $13.00
  • GCO $24.50
  • AVG Volume (30 Days)
  • CATX 1.5M
  • GCO 315.9K
  • Earning Date
  • CATX 08-11-2025
  • GCO 06-04-2025
  • Dividend Yield
  • CATX N/A
  • GCO N/A
  • EPS Growth
  • CATX N/A
  • GCO N/A
  • EPS
  • CATX N/A
  • GCO N/A
  • Revenue
  • CATX $1,471,000.00
  • GCO $2,341,438,000.00
  • Revenue This Year
  • CATX N/A
  • GCO $1.67
  • Revenue Next Year
  • CATX N/A
  • GCO $1.69
  • P/E Ratio
  • CATX N/A
  • GCO N/A
  • Revenue Growth
  • CATX N/A
  • GCO 1.85
  • 52 Week Low
  • CATX $1.60
  • GCO $16.19
  • 52 Week High
  • CATX $16.55
  • GCO $44.80
  • Technical
  • Relative Strength Index (RSI)
  • CATX 60.53
  • GCO 52.78
  • Support Level
  • CATX $2.96
  • GCO $21.24
  • Resistance Level
  • CATX $3.77
  • GCO $22.64
  • Average True Range (ATR)
  • CATX 0.41
  • GCO 1.39
  • MACD
  • CATX 0.02
  • GCO -0.06
  • Stochastic Oscillator
  • CATX 73.78
  • GCO 36.51

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

About GCO Genesco Inc.

Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.

Share on Social Networks: